Fund | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Columbia Variable Portfolio – Acorn Fund | $ | % (a) |
(a) | Annualized. |
Fund net assets | $ |
Total number of portfolio holdings | |
Portfolio turnover for the reporting period |
SPX Technologies, Inc. | % |
Churchill Downs, Inc. | % |
GCM Grosvenor, Inc., Class A | % |
Parsons Corp. | % |
Curtiss-Wright Corp. | % |
Wingstop, Inc. | % |
Five Below, Inc. | % |
Carlyle Group, Inc. (The) | % |
HealthEquity, Inc. | % |
Colliers International Group, Inc. | % |
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) The registrant’s “Schedule I – Investments in securities of unaffiliated issuers” (as set forth in 17 CFR 210.12-12) is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.
Not FDIC or NCUA Insured
|
No Financial Institution Guarantee
|
May Lose Value
|
Common Stocks 98.1%
|
||
Issuer
|
Shares
|
Value ($)
|
Consumer Discretionary 16.8%
|
||
Automobile Components 3.2%
|
||
Dorman Products, Inc.(a)
|
49,673
|
6,093,387
|
Modine Manufacturing Co.(a)
|
92,855
|
9,146,217
|
Total
|
|
15,239,604
|
Diversified Consumer Services 1.8%
|
||
Bright Horizons Family Solutions, Inc.(a)
|
67,138
|
8,297,585
|
Hotels, Restaurants & Leisure 5.9%
|
||
Churchill Downs, Inc.
|
110,406
|
11,151,006
|
Portillo’s, Inc., Class A(a)
|
378,039
|
4,411,715
|
Wingstop, Inc.
|
30,358
|
10,222,753
|
Xponential Fitness, Inc., Class A(a)
|
215,150
|
1,611,474
|
Total
|
|
27,396,948
|
Household Durables 3.7%
|
||
Cavco Industries, Inc.(a)
|
14,599
|
6,342,244
|
SharkNinja, Inc.(a)
|
19,738
|
1,953,865
|
TopBuild Corp.(a)
|
27,791
|
8,997,058
|
Total
|
|
17,293,167
|
Specialty Retail 2.2%
|
||
Five Below, Inc.(a)
|
77,193
|
10,126,178
|
Total Consumer Discretionary
|
78,353,482
|
|
Consumer Staples 4.8%
|
||
Consumer Staples Distribution & Retail 2.7%
|
||
BJ’s Wholesale Club Holdings, Inc.(a)
|
74,496
|
8,032,904
|
Sprouts Farmers Market, Inc.(a)
|
27,824
|
4,580,943
|
Total
|
|
12,613,847
|
Household Products 1.1%
|
||
WD-40 Co.
|
23,537
|
5,368,554
|
Personal Care Products 1.0%
|
||
elf Beauty, Inc.(a)
|
36,981
|
4,601,916
|
Total Consumer Staples
|
22,584,317
|
|
Energy 2.1%
|
||
Energy Equipment & Services 1.1%
|
||
TechnipFMC PLC
|
147,007
|
5,062,921
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Oil, Gas & Consumable Fuels 1.0%
|
||
Antero Resources Corp.(a)
|
114,632
|
4,617,377
|
Total Energy
|
9,680,298
|
|
Financials 9.6%
|
||
Banks 1.5%
|
||
Lakeland Financial Corp.
|
44,031
|
2,705,705
|
Western Alliance Bancorp
|
55,238
|
4,307,459
|
Total
|
|
7,013,164
|
Capital Markets 5.5%
|
||
Blue Owl Capital, Inc.
|
240,337
|
4,616,874
|
Carlyle Group, Inc. (The)
|
195,045
|
10,025,313
|
GCM Grosvenor, Inc., Class A
|
962,771
|
11,129,633
|
Total
|
|
25,771,820
|
Insurance 2.6%
|
||
Oscar Health, Inc., Class A(a)
|
115,842
|
2,483,652
|
Ryan Specialty Holdings, Inc., Class A
|
140,803
|
9,573,196
|
Total
|
|
12,056,848
|
Total Financials
|
44,841,832
|
|
Health Care 20.0%
|
||
Biotechnology 6.0%
|
||
Absci Corp.(a),(b)
|
382,504
|
983,035
|
BridgeBio Pharma, Inc.(a)
|
53,367
|
2,304,387
|
Crinetics Pharmaceuticals, Inc.(a)
|
28,140
|
809,307
|
Exact Sciences Corp.(a)
|
171,465
|
9,111,650
|
Insmed, Inc.(a)
|
64,769
|
6,518,352
|
Natera, Inc.(a)
|
15,206
|
2,568,902
|
Nuvalent, Inc., Class A(a)
|
23,590
|
1,799,917
|
Revolution Medicines, Inc.(a)
|
30,118
|
1,108,041
|
Sarepta Therapeutics, Inc.(a)
|
55,527
|
949,512
|
Vaxcyte, Inc.(a)
|
29,030
|
943,765
|
Viking Therapeutics, Inc.(a)
|
39,856
|
1,056,184
|
Total
|
|
28,153,052
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Health Care Equipment & Supplies 5.9%
|
||
Glaukos Corp.(a)
|
80,261
|
8,290,158
|
Integer Holdings Corp.(a)
|
47,106
|
5,792,625
|
iRhythm Technologies, Inc.(a)
|
12,380
|
1,906,025
|
Masimo Corp.(a)
|
47,576
|
8,003,235
|
Penumbra, Inc.(a)
|
14,602
|
3,747,311
|
Total
|
|
27,739,354
|
Health Care Providers & Services 4.6%
|
||
Alignment Healthcare, Inc.(a)
|
169,076
|
2,367,064
|
Encompass Health Corp.
|
59,788
|
7,331,803
|
HealthEquity, Inc.(a)
|
93,453
|
9,790,136
|
Pennant Group, Inc. (The)(a)
|
64,580
|
1,927,713
|
Total
|
|
21,416,716
|
Life Sciences Tools & Services 3.0%
|
||
Adaptive Biotechnologies Corp.(a)
|
118,129
|
1,376,203
|
BioLife Solutions, Inc.(a)
|
158,804
|
3,420,638
|
Bio-Techne Corp.
|
173,859
|
8,945,045
|
DNA Script(a),(c),(d),(e)
|
2,550
|
228,497
|
Total
|
|
13,970,383
|
Pharmaceuticals 0.5%
|
||
Corcept Therapeutics, Inc.(a)
|
14,677
|
1,077,292
|
Structure Therapeutics, Inc., ADR(a)
|
57,723
|
1,197,175
|
Total
|
|
2,274,467
|
Total Health Care
|
93,553,972
|
|
Industrials 25.4%
|
||
Aerospace & Defense 5.7%
|
||
Aerovironment, Inc.(a)
|
27,072
|
7,714,166
|
Axon Enterprise, Inc.(a)
|
2,712
|
2,245,373
|
Curtiss-Wright Corp.
|
21,565
|
10,535,581
|
Kratos Defense & Security Solutions, Inc.(a)
|
56,458
|
2,622,474
|
Moog, Inc., Class A
|
20,842
|
3,771,777
|
Total
|
|
26,889,371
|
Building Products 1.0%
|
||
Janus International Group, Inc.(a)
|
563,330
|
4,585,506
|
Commercial Services & Supplies 1.4%
|
||
VSE Corp.
|
49,546
|
6,489,535
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Construction & Engineering 3.0%
|
||
MYR Group, Inc.(a)
|
27,833
|
5,050,298
|
Sterling Infrastructure, Inc.(a)
|
38,634
|
8,914,023
|
Total
|
|
13,964,321
|
Electrical Equipment 0.8%
|
||
Atkore, Inc.
|
23,773
|
1,677,185
|
Bloom Energy Corp., Class A(a)
|
80,743
|
1,931,373
|
Total
|
|
3,608,558
|
Machinery 4.9%
|
||
Esab Corp.
|
41,985
|
5,061,292
|
Mueller Water Products, Inc., Class A
|
241,252
|
5,799,698
|
SPX Technologies, Inc.(a)
|
73,217
|
12,277,026
|
Total
|
|
23,138,016
|
Marine Transportation 1.4%
|
||
Matson, Inc.
|
59,127
|
6,583,792
|
Professional Services 4.3%
|
||
Alight, Inc., Class A
|
335,439
|
1,898,585
|
Parsons Corp.(a)
|
153,502
|
11,016,838
|
Paylocity Holding Corp.(a)
|
38,526
|
6,980,526
|
Total
|
|
19,895,949
|
Trading Companies & Distributors 2.9%
|
||
Applied Industrial Technologies, Inc.
|
26,591
|
6,181,078
|
FTAI Aviation Ltd.
|
65,485
|
7,533,394
|
Total
|
|
13,714,472
|
Total Industrials
|
118,869,520
|
|
Information Technology 17.3%
|
||
Electronic Equipment, Instruments & Components 3.2%
|
||
Celestica, Inc.(a)
|
47,426
|
7,403,673
|
Coherent Corp.(a)
|
50,158
|
4,474,595
|
Ingram Micro Holding Corp.
|
137,130
|
2,857,789
|
Total
|
|
14,736,057
|
IT Services 1.1%
|
||
Globant SA(a)
|
57,661
|
5,237,925
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Semiconductors & Semiconductor Equipment 1.7%
|
||
Lattice Semiconductor Corp.(a)
|
77,931
|
3,817,840
|
Marvell Technology, Inc.
|
30,687
|
2,375,174
|
Rigetti Computing, Inc.(a),(b)
|
32,444
|
384,786
|
Semtech Corp.(a)
|
34,844
|
1,572,858
|
Total
|
|
8,150,658
|
Software 11.1%
|
||
Alkami Technology, Inc.(a)
|
114,090
|
3,438,673
|
Atlassian Corp., Class A(a)
|
10,781
|
2,189,513
|
Braze, Inc., Class A(a)
|
62,898
|
1,767,434
|
Clearwater Analytics Holdings, Inc., Class A(a)
|
136,421
|
2,991,713
|
CyberArk Software Ltd.(a)
|
9,955
|
4,050,490
|
Dynatrace, Inc.(a)
|
93,620
|
5,168,760
|
Gen Digital, Inc.
|
160,675
|
4,723,845
|
Gitlab, Inc., Class A(a)
|
76,177
|
3,436,345
|
Monday.com Ltd.(a)
|
15,346
|
4,826,010
|
SailPoint, Inc.(a)
|
18,865
|
431,254
|
Sprout Social, Inc., Class A(a)
|
105,312
|
2,202,074
|
SPS Commerce, Inc.(a)
|
26,770
|
3,643,129
|
Varonis Systems, Inc.(a)
|
49,863
|
2,530,547
|
Vertex, Inc.(a)
|
84,014
|
2,968,635
|
Workiva, Inc., Class A(a)
|
40,452
|
2,768,939
|
Zeta Global Holdings Corp., Class A(a)
|
169,585
|
2,626,872
|
Zscaler, Inc.(a)
|
6,498
|
2,039,982
|
Total
|
|
51,804,215
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Technology Hardware, Storage & Peripherals 0.2%
|
||
IonQ, Inc.(a)
|
24,400
|
1,048,468
|
Total Information Technology
|
80,977,323
|
|
Real Estate 2.1%
|
||
Real Estate Management & Development 2.1%
|
||
Colliers International Group, Inc.
|
74,356
|
9,706,432
|
Total Real Estate
|
9,706,432
|
|
Total Common Stocks
(Cost $395,891,263)
|
458,567,176
|
|
|
||
Exchange-Traded Equity Funds 1.1%
|
||
|
Shares
|
Value ($)
|
Sector 1.1%
|
||
SPDR S&P Biotech ETF(b)
|
61,514
|
5,101,356
|
Total Exchange-Traded Equity Funds
(Cost $4,939,182)
|
5,101,356
|
|
|
||
Money Market Funds 2.3%
|
||
|
|
|
Columbia Short-Term Cash Fund, 4.473%(f),(g)
|
4,604,530
|
4,603,609
|
Dreyfus Government Cash Management Fund,
Institutional Shares, 4.209%(f),(h)
|
5,962,655
|
5,962,655
|
Total Money Market Funds
(Cost $10,565,130)
|
10,566,264
|
|
Total Investments in Securities
(Cost: $411,395,575)
|
474,234,796
|
|
Other Assets & Liabilities, Net
|
|
(6,843,784
)
|
Net Assets
|
467,391,012
|
(a)
|
Non-income producing investment.
|
(b)
|
All or a portion of this security was on loan at June 30, 2025. The total market value
of securities on loan at June 30, 2025 was $5,815,749.
|
(c)
|
Represents fair value as determined in good faith under procedures approved by the
Board of Trustees. At June 30, 2025, the total value of these securities amounted
to $228,497, which represents 0.05% of total net assets.
|
(d)
|
Denotes a restricted security, which is subject to legal or contractual restrictions
on resale under federal securities laws. Disposal of a restricted investment may involve time-consuming negotiations and expenses, and prompt sale at an acceptable
price may be difficult to achieve. Private placement securities are generally considered to be restricted, although certain of those securities may be traded between
qualified institutional investors under the provisions of Section 4(a)(2) and Rule 144A. The Fund will not incur any registration costs upon such a trade. These
securities are valued at fair value determined in good faith under consistently applied procedures approved by the Fund’s Board of Trustees. At June 30, 2025, the total market value of these securities amounted to $228,497, which represents 0.05% of total net assets. Additional information on these securities is as follows:
|
Security
|
Acquisition
Dates
|
Shares
|
Cost ($)
|
Value ($)
|
DNA Script
|
10/01/2021
|
2,550
|
2,223,535
|
228,497
|
(e)
|
Valuation based on significant unobservable inputs.
|
(f)
|
The rate shown is the seven-day current annualized yield at June 30, 2025.
|
(g)
|
Under Section 2(a)(3) of the Investment Company Act of 1940, an affiliated company is one in which the Fund owns 5% or more of the company’s outstanding voting securities, or a company which is under common ownership or control with the Fund.
The value of the holdings and transactions in these affiliated companies during the period ended June 30, 2025 are as follows:
|
Affiliated issuers
|
Beginning
of period($)
|
Purchases($)
|
Sales($)
|
Net change in
unrealized
appreciation
(depreciation)($)
|
End of
period($)
|
Realized gain
(loss)($)
|
Dividends($)
|
End of
period shares
|
Columbia Short-Term Cash Fund, 4.473%
|
||||||||
|
4,740,598
|
59,970,081
|
(60,107,493
)
|
423
|
4,603,609
|
102
|
119,090
|
4,604,530
|
(h)
|
Investment made with cash collateral received from securities lending activity.
|
ADR
|
American Depositary Receipt
|
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Total ($)
|
Investments in Securities
|
|
|
|
|
Common Stocks
|
|
|
|
|
Consumer Discretionary
|
78,353,482
|
—
|
—
|
78,353,482
|
Consumer Staples
|
22,584,317
|
—
|
—
|
22,584,317
|
Energy
|
9,680,298
|
—
|
—
|
9,680,298
|
Financials
|
44,841,832
|
—
|
—
|
44,841,832
|
Health Care
|
93,325,475
|
—
|
228,497
|
93,553,972
|
Industrials
|
118,869,520
|
—
|
—
|
118,869,520
|
Information Technology
|
80,977,323
|
—
|
—
|
80,977,323
|
Real Estate
|
9,706,432
|
—
|
—
|
9,706,432
|
Total Common Stocks
|
458,338,679
|
—
|
228,497
|
458,567,176
|
Exchange-Traded Equity Funds
|
5,101,356
|
—
|
—
|
5,101,356
|
Money Market Funds
|
10,566,264
|
—
|
—
|
10,566,264
|
Total Investments in Securities
|
474,006,299
|
—
|
228,497
|
474,234,796
|
Assets
|
|
Investments in securities, at value*
|
|
Unaffiliated issuers (cost $406,793,100)
|
$469,631,187
|
Affiliated issuers (cost $4,602,475)
|
4,603,609
|
Receivable for:
|
|
Capital shares sold
|
143,375
|
Dividends
|
38,100
|
Securities lending income
|
3,400
|
Foreign tax reclaims
|
3,686
|
Expense reimbursement due from Investment Manager
|
1,495
|
Total assets
|
474,424,852
|
Liabilities
|
|
Due upon return of securities on loan
|
5,962,655
|
Payable for:
|
|
Capital shares redeemed
|
519,260
|
Management services fees
|
30,350
|
Service fees
|
93,815
|
Compensation of chief compliance officer
|
47
|
Other expenses
|
44,862
|
Deferred compensation of board members
|
382,851
|
Total liabilities
|
7,033,840
|
Net assets applicable to outstanding capital stock
|
$467,391,012
|
Represented by
|
|
Paid in capital
|
444,038,437
|
Total distributable earnings (loss)
|
23,352,575
|
Total - representing net assets applicable to outstanding capital stock
|
$467,391,012
|
Shares outstanding
|
31,955,703
|
Net asset value per share
|
14.63
|
* Includes the value of securities on loan
|
5,815,749
|
Net investment income
|
|
Income:
|
|
Dividends — unaffiliated issuers
|
$1,082,451
|
Dividends — affiliated issuers
|
119,090
|
Income from securities lending — net
|
30,052
|
Foreign taxes withheld
|
(1,673
)
|
Total income
|
1,229,920
|
Expenses:
|
|
Management services fees
|
1,764,875
|
Service fees
|
286,064
|
Administration fees
|
60,951
|
Custodian fees
|
4,829
|
Printing and postage fees
|
29,466
|
Accounting services fees
|
15,930
|
Legal fees
|
11,645
|
Compensation of chief compliance officer
|
39
|
Compensation of board members
|
10,165
|
Deferred compensation of board members
|
(40,038
)
|
Other
|
11,081
|
Total expenses
|
2,155,007
|
Fees waived or expenses reimbursed by Investment Manager and its affiliates
|
(28,800
)
|
Total net expenses
|
2,126,207
|
Net investment loss
|
(896,287
)
|
Realized and unrealized gain (loss) — net
|
|
Net realized gain (loss) on:
|
|
Investments — unaffiliated issuers
|
12,886,646
|
Investments — affiliated issuers
|
102
|
Net realized gain
|
12,886,748
|
Net change in unrealized appreciation (depreciation) on:
|
|
Investments — unaffiliated issuers
|
(33,037,268
)
|
Investments — affiliated issuers
|
423
|
Net change in unrealized appreciation (depreciation)
|
(33,036,845
)
|
Net realized and unrealized loss
|
(20,150,097
)
|
Net decrease in net assets resulting from operations
|
$(21,046,384
)
|
|
Six Months Ended
June 30, 2025
(Unaudited)
|
Year Ended
December 31, 2024
|
Operations
|
|
|
Net investment loss
|
$(896,287
)
|
$(3,177,886
)
|
Net realized gain
|
12,886,748
|
68,581,650
|
Net change in unrealized appreciation (depreciation)
|
(33,036,845
)
|
4,536,539
|
Net increase (decrease) in net assets resulting from operations
|
(21,046,384
)
|
69,940,303
|
Decrease in net assets from capital stock activity
|
(27,871,373
)
|
(82,790,837
)
|
Total decrease in net assets
|
(48,917,757
)
|
(12,850,534
)
|
Net assets at beginning of period
|
516,308,769
|
529,159,303
|
Net assets at end of period
|
$467,391,012
|
$516,308,769
|
|
Six Months Ended
|
Year Ended
|
||
|
June 30, 2025 (Unaudited)
|
December 31, 2024
|
||
|
Shares
|
Dollars ($)
|
Shares
|
Dollars ($)
|
Capital stock activity
|
||||
|
|
|
|
|
Shares sold
|
270,950
|
3,681,668
|
332,200
|
4,719,350
|
Shares redeemed
|
(2,244,642
)
|
(31,553,041
)
|
(6,111,121
)
|
(87,510,187
)
|
Total net decrease
|
(1,973,692
)
|
(27,871,373
)
|
(5,778,921
)
|
(82,790,837
)
|
|
Six Months Ended
June 30, 2025
(Unaudited)
|
Year Ended December 31,
|
||||
2024
|
2023
|
2022
|
2021
|
2020
|
||
Per share data
|
|
|
|
|
|
|
Net asset value, beginning of period
|
$15.22
|
$13.33
|
$10.95
|
$25.74
|
$24.63
|
$22.26
|
Income from investment operations:
|
|
|
|
|
|
|
Net investment income (loss)
|
(0.03
)
|
(0.09
)
|
(0.04
)
|
(0.06
)
|
(0.19
)
|
(0.12
)
|
Net realized and unrealized gain (loss)
|
(0.56
)
|
1.98
|
2.42
|
(8.14
)
|
2.36
|
4.78
|
Total from investment operations
|
(0.59
)
|
1.89
|
2.38
|
(8.20
)
|
2.17
|
4.66
|
Less distributions to shareholders from:
|
|
|
|
|
|
|
Net investment income
|
—
|
—
|
—
|
—
|
(0.20
)
|
—
|
Net realized gains
|
—
|
—
|
—
|
(6.59
)
|
(0.86
)
|
(2.29
)
|
Total distributions to shareholders
|
—
|
—
|
—
|
(6.59
)
|
(1.06
)
|
(2.29
)
|
Net asset value, end of period
|
$14.63
|
$15.22
|
$13.33
|
$10.95
|
$25.74
|
$24.63
|
Total return
|
(3.88
%)
|
14.18
%(a)
|
21.74
%(a)
|
(33.46
%)
|
8.90
%
|
24.23
%
|
Ratios to average net assets
|
|
|
|
|
|
|
Total gross expenses(b)
|
0.93
%
|
0.99
%
|
0.99
%
|
1.01
%(c)
|
1.08
%
|
1.10
%
|
Total net expenses(b),(d)
|
0.92
%
|
0.95
%
|
0.96
%
|
1.01
%(c)
|
1.08
%
|
1.10
%
|
Net investment loss
|
(0.39
)%
|
(0.60
)%
|
(0.31
)%
|
(0.40
)%
|
(0.71
)%
|
(0.61
)%
|
Supplemental data
|
|
|
|
|
|
|
Portfolio turnover
|
43
%
|
82
%
|
65
%
|
119
%
|
70
%
|
92
%
|
Net assets, end of period (in thousands)
|
$467,391
|
$516,309
|
$529,159
|
$418,142
|
$685,554
|
$708,343
|
Notes to Financial Highlights
|
|
(a)
|
Had the Investment Manager and/or its affiliates not waived a portion of expenses,
total return would have been reduced.
|
(b)
|
In addition to the fees and expenses that the Fund bears directly, the Fund indirectly
bears a pro rata share of the fees and expenses of any other funds in which it invests. Such indirect expenses are not included in the Fund’s reported expense ratios.
|
(c)
|
Ratios include Trustees’ fees deferred during the current period as well as any gains or losses on the Trustees’ deferred compensation balances as a result of market fluctuations. If these had been excluded, expenses would have been higher by 0.01%.
|
(d)
|
Total net expenses include the impact of certain fee waivers/expense reimbursements
made by the Investment Manager and certain of its affiliates, if applicable.
|
|
Overnight and
continuous
|
Up to
30 days
|
30-90
days
|
Greater than
90 days
|
Total
|
Columbia Variable Portfolio – Acorn Fund
|
|
|
|
|
|
Securities lending transactions
|
|
|
|
|
|
Equity securities
|
$5,815,749
|
$—
|
$—
|
$—
|
$5,815,749
|
Gross amount of recognized liabilities for securities lending (collateral received)
|
|
|
|
|
5,962,655
|
Amounts due to counterparty in the event of default
|
|
|
|
|
$146,906
|
|
Goldman
Sachs ($)
|
Liabilities
|
|
Collateral on Securities Loaned
|
5,962,655
|
Total Liabilities
|
5,962,655
|
Total Financial and Derivative Net Assets
|
(5,962,655
)
|
Financial Instruments
|
5,815,749
|
Net Amount (a)
|
(146,906
)
|
(a)
|
Represents the net amount due from/(to) counterparties in the event of default.
|
Aggregate average daily net assets of the Trust
|
Annual
fee rate
|
Up to $4 billion
|
0.05%
|
$4 billion to $6 billion
|
0.04%
|
$6 billion to $8 billion
|
0.03%
|
$8 billion and over
|
0.02%
|
Federal
tax cost ($)
|
Gross unrealized
appreciation ($)
|
Gross unrealized
(depreciation) ($)
|
Net unrealized
appreciation ($)
|
411,396,000
|
96,440,000
|
(33,601,000
)
|
62,839,000
|
No expiration
short-term ($)
|
No expiration
long-term ($)
|
Total ($)
|
(42,572,098
)
|
(4,023,695
)
|
(46,595,793
)
|
Trustee
|
Votes for
|
Votes withheld
|
Abstentions
|
George S. Batejan
|
44,806,459
|
2,497,578
|
0
|
Daniel J. Beckman
|
44,545,549
|
2,758,489
|
0
|
Kathleen Blatz
|
44,841,283
|
2,462,755
|
0
|
Pamela G. Carlton
|
44,738,205
|
2,565,833
|
0
|
Janet Langford Carrig
|
44,923,713
|
2,380,324
|
0
|
J. Kevin Connaughton
|
44,851,008
|
2,453,030
|
0
|
Olive M. Darragh
|
44,634,747
|
2,669,291
|
0
|
Patricia M. Flynn
|
44,680,197
|
2,623,841
|
0
|
Brian J. Gallagher
|
44,768,699
|
2,535,339
|
0
|
Douglas A. Hacker
|
44,744,402
|
2,559,636
|
0
|
Nancy T. Lukitsh
|
44,975,413
|
2,328,625
|
0
|
David M. Moffett
|
44,601,579
|
2,702,459
|
0
|
Catherine James Paglia
|
44,611,075
|
2,692,963
|
0
|
Natalie A. Trunow
|
44,966,319
|
2,337,719
|
0
|
Sandra L. Yeager
|
44,920,389
|
2,383,649
|
0
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-End Management Investment Companies.
Proxy Disclosures for Open-End Management Investment Companies is included in Item 7 of this Form N-CSR.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.
The fees and expenses of the independent trustees are included in "Compensation of board members" and "Deferred compensation of board members" on each Fund's Statement of Operations as part of the Registrant's financial statements filed under Item 7 of this Form N-CSR. Additionally, the compensation paid by the Trust to the Chief Compliance Officer is included in "Compensation of chief compliance officer" on each Fund's Statement of Operations as part of the Registrant's financial statements filed under Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
Statement regarding basis for approval of Investment Advisory Contract is included in Item 7 of this Form N-CSR.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of directors implemented since the registrant last provided disclosure as to such procedures in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K or Item 15 of Form N-CSR.
Item 16. Controls and Procedures.
(a) The registrant’s principal executive officer and principal financial officer, based on their evaluation of the registrant’s disclosure controls and procedures as of a date within 90 days of the filing of this report, have concluded that such controls and procedures are adequately designed to ensure that information required to be disclosed by the registrant in Form N-CSR is accumulated and communicated to the registrant’s management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
(b) There was no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
(a)(1) Not applicable.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(registrant) | Columbia Funds Variable Series Trust |
By (Signature and Title) | /s/ Daniel J. Beckman |
Daniel J. Beckman, President and Principal Executive Officer | |
Date | August 21, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title) | /s/ Daniel J. Beckman |
Daniel J. Beckman, President and Principal Executive Officer | |
Date | August 21, 2025 |
By (Signature and Title) | /s/ Michael G. Clarke |
Michael G. Clarke, Chief Financial Officer, | |
Principal Financial Officer and Senior Vice President | |
Date | August 21, 2025 |
By (Signature and Title) | /s/ Charles H. Chiesa |
Charles H. Chiesa, Treasurer, Chief Accounting | |
Officer and Principal Financial Officer | |
Date | August 21, 2025 |